Isracann Biosciences (Isracann Biosciences) EV-to-EBITDA : 0.04 (As of Jun. 14, 2024)

Isracann Biosciences EV-to-EBITDA Chart

Isracann Biosciences Annual Data
	Trend	May13	May14	May15	May16	May17	May18	May19	May20	May21	May22
EV-to-EBITDA		Get a 7-Day Free Trial					-13.15	-1.85	-2.00	-1.21	-2.34

Isracann Biosciences Quarterly Data
	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22
EV-to-EBITDA	Get a 7-Day Free Trial															-0.53	-0.38	-0.60	-2.34	-1.40

Competitive Comparison of Isracann Biosciences's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Isracann Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isracann Biosciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isracann Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Isracann Biosciences's EV-to-EBITDA falls into.

Isracann Biosciences EV-to-EBITDA Calculation

Isracann Biosciences's EV-to-EBITDA for today is calculated as:

Isracann Biosciences's current Enterprise Value is $-0.14 Mil.
Isracann Biosciences's EBITDA for the trailing twelve months (TTM) ended in Aug. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isracann Biosciences  (OTCPK:ISCNF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Isracann Biosciences's PE Ratio for today is calculated as:

Isracann Biosciences's share price for today is $0.0001.
Isracann Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.029.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Isracann Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Isracann Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Isracann Biosciences (Isracann Biosciences) Business Description